Ran Jin

6PUBLICATIONS
32CO-AUTHORS
Epidemiological modellingCardiology (incl. cardiovascular diseases)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 18, 2026
Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events: A Cohort Study.

|Feb 20, 2026
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems.

Nishant P Shah, Eric D Peterson, Peter Shrader

|Mar 11, 2025
Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme.

Ran Jin, James M Haughton, Emily J Goddard

|Mar 04, 2024
Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.

Ran Jin, Silvia Kruppert, Florian Scholz

|Nov 13, 2023
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe.

Ran Jin, Chidozie Nduka, Delphine Courmier

|Oct 21, 2014
Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease.

Ran Jin, Andrew Willment, Shivani S Patel

Pageof 1

Frequent Collaborators

2 joint publications

Delphine Courmier

2 joint publications

Rachael Meadows

2 joint publications

James Piercy

2 joint publications

Waldemar Radziszewski